ImmunoPrecise Antibodies (OTCMKTS:IPATF) Trading 9.3% Higher – Time to Buy?

Shares of ImmunoPrecise Antibodies Ltd. ( OTCMKTS:IPATF – Get Free Report ) rose 9.3% on Friday .

The stock traded as high as $0.45 and last traded at $0.45.



Approximately 285,512 shares traded hands during mid-day trading, an increase of 1,305% from the average daily volume of 20,327 shares. The stock had previously closed at $0.41.

ImmunoPrecise Antibodies Trading Up 9.3 % The business has a fifty day moving average price of $0.42 and a 200-day moving average price of $0.

66. ImmunoPrecise Antibodies Company Profile ( Get Free Report ) ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services.

It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization. Featured Stories Five stocks we like better than ImmunoPrecise Antibodies ETF Screener: Uses and Step-by-Step Guide Insiders Are Selling, But These 3 Stocks Are Must-Buys What Are Trending Stocks? Trending Stocks Explained Rivian Defies Doubters: Delivery Triumph Fuels Stock Surge Diversification Can Smooth Returns And Mitigate Portfolio Risk Hindenburg Short Report Slams Carvana Over Alleged ‘Grift’ Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.

com's FREE daily email newsletter ..